FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> software | pricing | SaaS

Negotiate software licenses now

Free Newsletter

FierceBiotech IT updates senior biotech, pharma, and IT leaders on how IT advances are shaping clinical trials and clinical research. Get your weekly briefing on clinical trial design and management systems, adaptive trials, eClinical trials, and more. Sign up today!



Tools

This is the time to negotiate steep discounts for traditional on-premise software, according to 60 percent of respondents to an IDC survey. Organizations are highly interested in software pricing options that help shift spending from capital budgets to operating budgets. "In this economy, traditional licensing approaches are under fire, with steep license discounts and maintenance concessions the norm," says Amy Konary of IDC. "To survive the downturn, software companies have to evolve their go-to-market approach and subscription pricing and SaaS will play a key role." Release


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotechIT Email Newsletter:

More stories about software   pricing   SaaS